TRANSGENE SA - France 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 1
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0.25*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 7.057.980 0 1
2019 0 10.999.316 0 1
2018 0 3.942.861 0 1
2015 0 18.200.000 0 1
2012 1.992.214 0 570.009 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASTRAZENECA2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
UNIVERSITAET BASEL2
UNIVERSITAETSKLINIKUM JENA2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT TWENTE2
ACADEMISCH ZIEKENHUIS LEIDEN1
AERAS GLOBAL TB VACCINE FOUNDATION1
ASTON UNIVERSITY1
AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO1
Bangor University1
BAYER1
BIOSCI CONSULTING BVBA1
BLUEBIRD BIO INC1
BUNDESINSTITUT FUER RISIKOBEWERTUNG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY1
COVANCE LABORATORIES1
DEPARTMENT OF HEALTH1
DYNAMIC421
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EDUCATIONAL FOUNDATION YONSEI UNIVERSITY1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
F HOFFMANNLA ROCHE1
FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA1
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE1
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT1
FUDAN UNIVERSITY SHANGHAI CANCER CENTER1
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL1
FUNDACIO INSTITUT DE RECERCA BIOMEDICA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GENOME RESEARCH1
GLAXOSMITHKLINE BIOLOGICALS1
HOSPICES CANTONAUX CHUV1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT DE RECHERCHES SERVIER1
INSTITUT PASTEUR1
INSTITUT PASTEUR DE LILLE1
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE1
INTERNATIONAL TUBERCULOSIS RESEARCH CENTER1
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI1
ISTITUTO SUPERIORE DI SANITA1
JDRF INTERNATIONAL1
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW1
KWAZULU NATAL RESEARCH INSTITUTE FOR TBHIV NPC1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE1
LUND UNIVERSITY1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICAL RESEARCH COUNCIL1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK SHARP & DOHME CORP1
MILTENYI BIOTEC1
NOVARTIS PHARMA1
PAUL EHRLICH INSTITUT1
PYRO SCIENCE1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
SANOFIAVENTIS1
SINGLE CELL DISCOVERIES BV1
STATENS SERUM INSTITUT1
STELLENBOSCH UNIVERSITY1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
STICHTING HUBRECHT ORGANOID TECHNOLOGY1
STICHTING INSTITUTE FOR HUMAN ORGAN AND DISEASE MODEL TECHNOLOGIES1
STICHTING LYGATURE1
STICHTING ONCODE INSTITUTE1
STICHTING TUBERCULOSIS VACCINE INITIATIVE1
TCURX1
TECHNISCHE UNIVERSITAET GRAZ1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE SECRETARY OF STATE FOR ENVIRONMENT FOOD AND RURAL AFFAIRS1
THE UNIVERSITY OF SYDNEY1
THE UNIVERSITY OF TUEBINGEN1
UNIVERSIDAD DE ZARAGOZA1
UNIVERSITAET BERN1
UNIVERSITAET LEIPZIG1
UNIVERSITAET ULM1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITE DE GENEVE1
UNIVERSITE DE LAUSANNE1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITEIT GENT1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN1
UNIVERSITY OF CAPE TOWN1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF OSLO1
UNIVERSITY OF STRATHCLYDE1
UPMKYMMENE OYJ1
UPPSALA UNIVERSITET1
XENOPAT SL1

Constancy:

Total number of partners: 109
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 109
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2015-01-01TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development TBVAC2020participant18.200.00044
2012-01-01Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China IMMUNOCANcoordinator1.992.2145

Alias institution names:

  • TRANSGENE